How nerves fuel prostate cancer growth
Researchers from the Albert Einstein College of Medicine have pinpointed how certain nerves drive the growth of prostate cancer using a metabolic 'switch.'
Hormone therapy for prostate cancer increases cardiac risk
Androgen-deprivation therapy is widely used to treat prostate cancer. In a recent study, the potential risks to heart health are examined.
Everything you need to know about prostate nodules
A prostate nodule is a firm, knuckle-like area on the prostate. There are several causes of prostate nodules, including prostatitis and prostate cancer.
All you need to know about the PCA3 test
The PCA3 test can help doctors diagnose prostate cancer. Learn about the test, what to expect, and other testing options with this article.
Despite concerns, vasectomy and prostate cancer not linked
A debate that has raged for more than 30 years may finally be over: prostate cancer risk does not seem to be increased following a vasectomy.
Frequent ejaculation and prostate cancer: What's the link?
Prostate cancer is one of the most common types of cancer that affects men. Could frequent ejaculation help reduce the risk of getting this disease?
Prostate cancer: Could a breast cancer drug reduce recurrence?
Researchers have found that PARP inhibitors - a class of drugs used to treat breast cancer - may also benefit men with prostate cancer.
Prostate cancer: PSA screening does lower death risk, says review
A new review suggests that - contrary to current USPSTF guidelines - PSA screening significantly reduces the risk of death to prostate cancer.
Prostate cancer: Study identifies earlier clinical trial endpoint that can be used to indicate effectiveness of new treatments
Scientists say they have validated a "surrogate endpoint" - a reliable statistical shortcut in a clinical trial - that could accelerate testing of new adjuvant therapies aimed at reducing deaths from...
Arno Therapeutics enrolls first patient in a Phase I/II trial evaluating onapristone in men with advanced castration-resistant prostate cancer
Arno Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, has announced that it has enrolled the first patient in a Phase I/II trial...